0000895813-21-000015.txt : 20211117 0000895813-21-000015.hdr.sgml : 20211117 20211117094610 ACCESSION NUMBER: 0000895813-21-000015 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201215 FILED AS OF DATE: 20211117 DATE AS OF CHANGE: 20211117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hopper Paul CENTRAL INDEX KEY: 0001355220 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39788 FILM NUMBER: 211418732 MAIL ADDRESS: STREET 1: 7982 DOUG HILL CITY: SAN DIEGO STATE: CA ZIP: 92127 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Scopus BioPharma Inc. CENTRAL INDEX KEY: 0001772028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821248020 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE, SUITE 300 CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: (212) 479-2513 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE, SUITE 300 CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: Scopus Biopharma Inc. DATE OF NAME CHANGE: 20190327 3 1 ownership.xml X0206 3 2020-12-15 0 0001772028 Scopus BioPharma Inc. SCPS 0001355220 Hopper Paul 101/50 MCLACHLAN AVENUE RUSHCUTTERS BAY C3 2011 AUSTRALIA 1 0 0 0 Common Stock 700000 I By Moreglade Pty. Limited Common Stock 6333 D W Warrant 2021-10-01 2026-09-30 B Unit 503636 I By Moreglade Pty. Limited W Warrant 2021-10-01 2026-09-30 B Unit 4557 D Mr. Hopper is a director of Moreglade Pty. Limited and therefore is deemed to have shared voting and dispositive power over the shares of Common Stock and W Warrants held by this entity. Mr. Hopper disclaims beneficial ownership of the shares of Common Stock and W Warrants held by this entity, as he has no pecuniary interest therein. Excludes 6,333 shares owned by Mr. Hopper's spouse and an aggregate of 50,668 shares owned by Mr. Hopper's adult children, as to which shares he disclaims beneficial ownership. Each W Warrant is exercisable for one B Unit. Starting on April 1, 2022, each B Unit can be separated into one share of common stock and one Z Warrant. Each Z Warrant is exercisable for one share of common stock with an exercise price of $5.00 per share. The Z Warrant will become exercisable on July 1, 2022 and will expire on June 30, 2027. Excludes 4,557 W Warrants owned by Mr. Hopper's spouse and an aggregate of 36,452 W Warrants owned by Mr. Hopper's adult children, as to which warrants he disclaims beneficial ownership. /s/ Paul Hopper 2021-11-17